000 | 01413nam a2200229Ia 4500 | ||
---|---|---|---|
003 | NULRC | ||
005 | 20250520102657.0 | ||
008 | 250520s9999 xx 000 0 und d | ||
020 | _a9781405194716 | ||
040 | _cNULRC | ||
050 | _aRM 302.5 .W35 2010 | ||
100 |
_aWaller, Patrick _eauthor |
||
245 | 3 |
_aAn introduction to pharmacovigilance / _cPatrick Waller |
|
260 |
_aChichester, England : _bJohn Wiley & Son, Inc., _cc2010 |
||
300 |
_axiii, 106 pages : _billustrations ; _c22 cm. |
||
365 | _bUSD31.23 | ||
504 | _aIncludes index. | ||
505 | _aWhat is pharmacovigilance and how has it developed? -- Basic concepts -- Types and sources of data -- The process of pharmacovigilance -- Regulatory aspects of pharmacovigilance -- International collaboration -- Ethical and societal considerations -- Future directions -- Learning more about pharmacovigilance | ||
520 | _aPharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems. This introductory guide is designed to aid the rapid understanding of the key principles of pharmacovigilance. Packed full of examples illustrating drug safety issues it not only covers the processes involved, but the regulatory aspects and ethical and societal considerations of pharmacovigilance. | ||
650 | _aDRUGS -- SIDE EEFECTS | ||
942 |
_2lcc _cBK |
||
999 |
_c12869 _d12869 |